PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsPeg3350
Peg3350
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
150 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
ConstipationD003248—K59.027824848
ColonoscopyD003113————86923
Colorectal neoplasmsD015179——11—417
Digestive system diseasesD004066EFO_0000405K92.9—2—114
Colonic neoplasmsD003110—C18——31—4
Brain diseasesD001927—G93.40———123
Hepatic encephalopathyD006501—K72.91———123
FibrosisD005355—————123
Fecal impactionD005244—K56.41—1—2—3
Gastrointestinal diseasesD005767———2—1—3
Show 30 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hiv infectionsD015658EFO_0000764B20—13——4
InfectionsD007239EFO_0000544——22——3
Acquired immunodeficiency syndromeD000163EFO_0000765B20—12——3
Immunologic deficiency syndromesD007153—D84.9—11——2
Critical illnessD016638————1—12
Post-traumatic stress disordersD013313EFO_0001358F43.1—11——1
Clostridioides difficileD016360NCBITaxon_1496——11——1
EndoscopyD004724————1——1
Hiv-1D015497————1——1
Gender dysphoriaD000068116—F64—11——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Crohn diseaseD003424EFO_0000384K5024———4
DiarrheaD003967—R19.7—2———2
Autism spectrum disorderD000067877—F84.0—2———2
Communicable diseasesD003141———1———1
Peripheral nerve injuriesD059348——11———1
Autistic disorderD001321EFO_0003758F84.0—1———1
Coronary artery diseaseD003324—I25.1—1———1
InflammationD007249MP_0001845——1———1
AtherosclerosisD050197EFO_0003914I25.1—1———1
Adenomatous polypsD018256—D28—1———1
Show 2 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Pancreatic ductal carcinomaD021441——1————1
AdenocarcinomaD000230——1————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Liver cirrhosisD008103EFO_0001422K74.0————22
Intestinal diseasesD007410—K63.9————22
Pregnancy rateD018873——————11
HemorrhoidsD006484EFO_0009552K64————11
Fecal incontinenceD005242—R15————11
Type 2 diabetes mellitusD003924EFO_0001360E11————11
Diabetes mellitusD003920EFO_0000400E08-E13————11
Type 1 diabetes mellitusD003922EFO_0001359E10————11
SyndromeD013577——————11
Digestive system endoscopyD016145——————11
Show 10 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name—
INN—
Description
—
Classification
Unknown
Drug class—
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)—
Identifiers
PDB—
CAS-ID—
RxCUI—
ChEMBL ID—
ChEBI ID—
PubChem CID—
DrugBank—
UNII ID—
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
20 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use